首页 > 最新文献

Health affairs scholar最新文献

英文 中文
Accessibility of diabetes education in the United States: barriers, policy implications, and the road ahead. 美国糖尿病教育的可及性:障碍、政策影响和未来之路。
Pub Date : 2024-08-21 eCollection Date: 2024-08-01 DOI: 10.1093/haschl/qxae097
Anna Tharakan, Eugenia McPeek Hinz, Emelia Zhu, Brad Denmeade, Jashalynn German, Wei Angel Huang, Amanda Brucker, Joanne Rinker, Chris Memering, Susan Spratt

Diabetes Self-Management Education and Support (DSMES) programs are an effective, yet underutilized, resource to improve health outcomes and behaviors for people with diabetes. We examined the attendance and referral rates for people with diabetes to DSMES classes at an academic medical center, noting a 10% referral rate and 37% completion rate for those referred. We identified barriers to DSMES care at patient, provider, and health system levels. Current technology platforms and training fail to prioritize referrals to diabetes education; providers and people with diabetes are often unfamiliar with program content and benefits. Scheduling mechanisms often delay or lose interested patients in receiving vital education. Existing Medicare reimbursement strategies limit expansion of DSMES programs, generating significant wait times and limit capabilities for Diabetes Care and Education Specialists. We identify potential policy solutions and recommend alterations to existing referral and scheduling systems to expand existing technology platforms for DSMES programs and shift reimbursement policies to individualize and better support care for persons with diabetes.

糖尿病自我管理教育和支持(DSMES)计划是一种有效但未得到充分利用的资源,可改善糖尿病患者的健康状况和行为。我们对一家学术医疗中心的糖尿病患者参加 DSMES 课程的人数和转介率进行了调查,发现转介率为 10%,转介者的完成率为 37%。我们发现了患者、医疗服务提供者和医疗系统在 DSMES 护理方面存在的障碍。当前的技术平台和培训未能优先考虑糖尿病教育转介;医疗服务提供者和糖尿病患者往往不熟悉项目内容和益处。日程安排机制经常会延误或失去有兴趣接受重要教育的患者。现有的医疗保险报销策略限制了 DSMES 项目的扩展,导致大量等待时间,并限制了糖尿病护理和教育专家的能力。我们确定了潜在的政策解决方案,并建议改变现有的转诊和排期系统,以扩展 DSMES 计划的现有技术平台,并改变报销政策,使糖尿病患者的护理个性化并得到更好的支持。
{"title":"Accessibility of diabetes education in the United States: barriers, policy implications, and the road ahead.","authors":"Anna Tharakan, Eugenia McPeek Hinz, Emelia Zhu, Brad Denmeade, Jashalynn German, Wei Angel Huang, Amanda Brucker, Joanne Rinker, Chris Memering, Susan Spratt","doi":"10.1093/haschl/qxae097","DOIUrl":"https://doi.org/10.1093/haschl/qxae097","url":null,"abstract":"<p><p>Diabetes Self-Management Education and Support (DSMES) programs are an effective, yet underutilized, resource to improve health outcomes and behaviors for people with diabetes. We examined the attendance and referral rates for people with diabetes to DSMES classes at an academic medical center, noting a 10% referral rate and 37% completion rate for those referred. We identified barriers to DSMES care at patient, provider, and health system levels. Current technology platforms and training fail to prioritize referrals to diabetes education; providers and people with diabetes are often unfamiliar with program content and benefits. Scheduling mechanisms often delay or lose interested patients in receiving vital education. Existing Medicare reimbursement strategies limit expansion of DSMES programs, generating significant wait times and limit capabilities for Diabetes Care and Education Specialists. We identify potential policy solutions and recommend alterations to existing referral and scheduling systems to expand existing technology platforms for DSMES programs and shift reimbursement policies to individualize and better support care for persons with diabetes.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The state of health information organizations and plans to participate in the federal exchange framework. 医疗信息组织和计划参与联邦交换框架的情况。
Pub Date : 2024-08-21 eCollection Date: 2024-08-01 DOI: 10.1093/haschl/qxae098
Jordan Everson, Wei Chang, Vaishali Patel, Julia Adler-Milstein

In late 2023, the Office of the National Coordinator for Health Information Technology launched the Trusted Exchange Framework and Common Agreement (TEFCA) to enable nationwide health information exchange. Regional, local, and state health information organizations (HIOs) will be key components of nationwide exchange, and TEFCA could broaden HIOs' access to information. However, HIOs can choose whether to participate. We conducted a national survey of HIOs in 2023 to assess their plans to participate in TEFCA and broader measures of maturity. We identified 76 operational HIOs, down from 89 in 2019. These HIOs operated in 47 states and contained over 600 million patient records, indicating some duplication. Sixty-three percent of HIOs planned to participate in TEFCA, up 7 percentage points from 2019, and 32% of HIOs indicated that they did not know if they would participate. Health information organizations already engaged in exchange with other networks were more likely to plan to participate. The most common barrier (44%) was having not developed a strategic plan for TEFCA participation. While TEFCA appears to have successfully engaged the majority of HIOs, achieving nationwide exchange will require policy efforts to either attract the remaining HIOs or ensure that nonparticipating HIOs' providers have another option for TEFCA participation.

2023 年底,美国国家卫生信息技术协调员办公室启动了 "可信交换框架和共同协议"(TEFCA),以实现全国范围内的卫生信息交换。地区、地方和州卫生信息组织(HIOs)将是全国范围交换的关键组成部分,TEFCA 可以扩大 HIOs 对信息的访问。但是,医疗信息组织可以选择是否参与。我们在 2023 年对 HIO 进行了一次全国性调查,以评估其参与 TEFCA 的计划和更广泛的成熟度衡量标准。我们确定了 76 家正在运营的 HIO,少于 2019 年的 89 家。这些 HIO 在 47 个州运营,包含 6 亿多份患者记录,表明存在一些重复。63%的 HIO 计划参与 TEFCA,比 2019 年增加了 7 个百分点,32% 的 HIO 表示不知道是否会参与。已经与其他网络进行交换的医疗信息组织更有可能计划参与。最常见的障碍(44%)是没有制定参与 TEFCA 的战略计划。尽管 TEFCA 似乎已经成功地吸引了大多数 HIO 的参与,但要实现全国范围内的交换,还需要在政策上做出努力,以吸引其余的 HIO,或确保未参与的 HIO 的医疗服务提供者有另一种参与 TEFCA 的选择。
{"title":"The state of health information organizations and plans to participate in the federal exchange framework.","authors":"Jordan Everson, Wei Chang, Vaishali Patel, Julia Adler-Milstein","doi":"10.1093/haschl/qxae098","DOIUrl":"10.1093/haschl/qxae098","url":null,"abstract":"<p><p>In late 2023, the Office of the National Coordinator for Health Information Technology launched the Trusted Exchange Framework and Common Agreement (TEFCA) to enable nationwide health information exchange. Regional, local, and state health information organizations (HIOs) will be key components of nationwide exchange, and TEFCA could broaden HIOs' access to information. However, HIOs can choose whether to participate. We conducted a national survey of HIOs in 2023 to assess their plans to participate in TEFCA and broader measures of maturity. We identified 76 operational HIOs, down from 89 in 2019. These HIOs operated in 47 states and contained over 600 million patient records, indicating some duplication. Sixty-three percent of HIOs planned to participate in TEFCA, up 7 percentage points from 2019, and 32% of HIOs indicated that they did not know if they would participate. Health information organizations already engaged in exchange with other networks were more likely to plan to participate. The most common barrier (44%) was having not developed a strategic plan for TEFCA participation. While TEFCA appears to have successfully engaged the majority of HIOs, achieving nationwide exchange will require policy efforts to either attract the remaining HIOs or ensure that nonparticipating HIOs' providers have another option for TEFCA participation.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11346357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential impacts of the COVID-19 pandemic on mental health service access among Medicaid-enrolled individuals. COVID-19 大流行对参加医疗补助计划的个人获得心理健康服务的不同影响。
Pub Date : 2024-08-20 eCollection Date: 2024-09-01 DOI: 10.1093/haschl/qxae104
K John McConnell, Sara Edelstein, Courtney Benjamin Wolk, Stephan Lindner, Jane M Zhu

The COVID-19 public health emergency (PHE) caused significant disruptions in the delivery of care, with in-person visits decreasing and telehealth use increasing. We investigated the impact of these changes on mental health services for Medicaid-enrolled adults and youth in Washington State. Among enrollees with existing mental health conditions, the first year of the PHE was associated with a surge in specialty outpatient mental health visits (13% higher for adults and 7% higher for youth), returning to pre-PHE levels in the second year. Conversely, youth with new mental health needs experienced a decline in specialty outpatient visit rates by ∼15% and 37% in the first and second years of the PHE, respectively. These findings indicate that while mental health service use was maintained or improved for established patients, these patterns did not extend to Medicaid-enrolled youth with new mental health needs, potentially due to barriers such as difficulty in finding providers and establishing new patient-provider relationships remotely. To bridge this gap, there is a need for a multi-faceted approach that includes improving service accessibility, enhancing provider availability, and optimizing initial care encounters, whether in-person or virtual, to better support new patients.

COVID-19 公共卫生紧急事件(PHE)对医疗服务的提供造成了极大的干扰,亲自就诊的人数减少,而远程医疗的使用人数增加。我们调查了这些变化对华盛顿州参加医疗补助计划的成人和青少年心理健康服务的影响。在已有心理健康问题的参保者中,PHE 实施的第一年与专科门诊心理健康就诊量激增有关(成人增加 13%,青少年增加 7%),第二年则恢复到 PHE 实施前的水平。相反,在公共健康教育的第一年和第二年,有新心理健康需求的青少年的专科门诊就诊率分别下降了 15% 和 37%。这些研究结果表明,虽然心理健康服务的使用在既有患者身上得到了维持或改善,但这些模式并没有延伸到有新心理健康需求的医疗补助参保青少年身上,这可能是由于难以远程找到医疗服务提供者和建立新的患者-医疗服务提供者关系等障碍造成的。为了弥补这一差距,需要采取多方面的方法,包括改善服务的可及性、提高医疗服务提供者的可用性、优化初次就诊(无论是面对面还是虚拟就诊),以更好地支持新患者。
{"title":"Differential impacts of the COVID-19 pandemic on mental health service access among Medicaid-enrolled individuals.","authors":"K John McConnell, Sara Edelstein, Courtney Benjamin Wolk, Stephan Lindner, Jane M Zhu","doi":"10.1093/haschl/qxae104","DOIUrl":"10.1093/haschl/qxae104","url":null,"abstract":"<p><p>The COVID-19 public health emergency (PHE) caused significant disruptions in the delivery of care, with in-person visits decreasing and telehealth use increasing. We investigated the impact of these changes on mental health services for Medicaid-enrolled adults and youth in Washington State. Among enrollees with existing mental health conditions, the first year of the PHE was associated with a surge in specialty outpatient mental health visits (13% higher for adults and 7% higher for youth), returning to pre-PHE levels in the second year. Conversely, youth with new mental health needs experienced a decline in specialty outpatient visit rates by ∼15% and 37% in the first and second years of the PHE, respectively. These findings indicate that while mental health service use was maintained or improved for established patients, these patterns did not extend to Medicaid-enrolled youth with new mental health needs, potentially due to barriers such as difficulty in finding providers and establishing new patient-provider relationships remotely. To bridge this gap, there is a need for a multi-faceted approach that includes improving service accessibility, enhancing provider availability, and optimizing initial care encounters, whether in-person or virtual, to better support new patients.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363869/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An increasing number of states filled Conrad 30 waivers for recruiting international medical graduates. 越来越多的州为招聘国际医学毕业生填写了康拉德 30 号豁免书。
Pub Date : 2024-08-19 eCollection Date: 2024-09-01 DOI: 10.1093/haschl/qxae103
Tarun Ramesh, Sarah E Brotherton, Gregory D Wozniak, Hao Yu

To address physician shortages in the United States, Congress created the Conrad 30 visa waiver program allowing non-citizen international medical graduates to obtain visas to practice medicine in underserved areas. There is little information on whether states have effectively used the program. To fill the gap, we examined the growth and distribution of Conrad physicians between 2001 and 2020. We found that the number of states filling all of their annual allocated Conrad slots increased over the last two decades, yet one-half of the states still did not fill their allowed slots in 2020. Our analysis also revealed substantial variations across states in the number of Conrad physicians by specialty (eg, primary care physicians and psychiatrists), geography (eg, rural vs urban areas and physician shortage vs non-shortage areas). Our findings suggest that states can better use the Conrad program to meet healthcare needs across specialties and geographic areas.

为了解决美国医生短缺的问题,美国国会制定了康拉德 30 免签证计划,允许非公民的国际医学毕业生获得签证,在医疗服务不足的地区行医。关于各州是否有效利用该计划的信息很少。为了填补这一空白,我们研究了 2001 年至 2020 年间康拉德医生的增长和分布情况。我们发现,在过去二十年中,有更多的州填满了每年分配的康拉德名额,但到 2020 年,仍有二分之一的州没有填满允许的名额。我们的分析还显示,各州的康拉德医生数量在专业(如初级保健医生和精神科医生)、地域(如农村地区与城市地区、医生短缺地区与非短缺地区)方面存在巨大差异。我们的研究结果表明,各州可以更好地利用康拉德计划来满足不同专业和不同地域的医疗需求。
{"title":"An increasing number of states filled Conrad 30 waivers for recruiting international medical graduates.","authors":"Tarun Ramesh, Sarah E Brotherton, Gregory D Wozniak, Hao Yu","doi":"10.1093/haschl/qxae103","DOIUrl":"10.1093/haschl/qxae103","url":null,"abstract":"<p><p>To address physician shortages in the United States, Congress created the Conrad 30 visa waiver program allowing non-citizen international medical graduates to obtain visas to practice medicine in underserved areas. There is little information on whether states have effectively used the program. To fill the gap, we examined the growth and distribution of Conrad physicians between 2001 and 2020. We found that the number of states filling all of their annual allocated Conrad slots increased over the last two decades, yet one-half of the states still did not fill their allowed slots in 2020. Our analysis also revealed substantial variations across states in the number of Conrad physicians by specialty (eg, primary care physicians and psychiatrists), geography (eg, rural vs urban areas and physician shortage vs non-shortage areas). Our findings suggest that states can better use the Conrad program to meet healthcare needs across specialties and geographic areas.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11364145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Over- and underreporting of prices: most hospitals are not compliant with the Hospital Price Transparency Rule. 多报或少报价格:大多数医院不遵守《医院价格透明规则》。
Pub Date : 2024-08-19 eCollection Date: 2024-09-01 DOI: 10.1093/haschl/qxae099
Mitchell Mead, Andrew M Ibrahim

Concern has been raised about the effectiveness of the Hospital Price Transparency Rule to facilitate a clear understanding of health care prices due to poor reporting by hospitals. However, the relationship between what services the hospital provides and what prices they report is not clear. We assessed reported prices in the Turquoise Health database and compared them at the hospital level with the CMS Provider of Services File to identify if a shoppable service was provided at a hospital. We found significant mismatch between the hospital prices being reported and the services being provided. For example, 56% of hospitals providing at least 1 shoppable service that requires public price reporting did not report any prices. Of hospitals reporting prices, most hospitals (66%) reported prices for only a portion of the services they provide. In addition, 12% of hospitals reported prices for services they do not provide. Only 6% of hospitals had complete concordance with price reporting and services they actually provide. Current compliance enforcement and penalties do not appear to be adequate to achieve the goals of the Hospital Price Transparency Rule.

由于医院报告不力,人们对《医院价格透明规则》在促进清楚了解医疗价格方面的有效性表示担忧。然而,医院提供的服务与医院报告的价格之间的关系并不明确。我们评估了 Turquoise Health 数据库中的报告价格,并将医院层面的价格与 CMS 服务提供者文件进行比较,以确定医院是否提供了可购物的服务。我们发现,医院报告的价格与提供的服务之间存在严重的不匹配。例如,在至少提供一项需要公开价格报告的可购物服务的医院中,56% 的医院没有报告任何价格。在报告价格的医院中,大多数医院(66%)只报告了部分服务的价格。此外,有 12% 的医院报告了其不提供的服务的价格。只有 6% 的医院的价格报告与实际提供的服务完全一致。目前的合规执行和处罚措施似乎不足以实现《医院价格透明规则》的目标。
{"title":"Over- and underreporting of prices: most hospitals are not compliant with the Hospital Price Transparency Rule.","authors":"Mitchell Mead, Andrew M Ibrahim","doi":"10.1093/haschl/qxae099","DOIUrl":"10.1093/haschl/qxae099","url":null,"abstract":"<p><p>Concern has been raised about the effectiveness of the Hospital Price Transparency Rule to facilitate a clear understanding of health care prices due to poor reporting by hospitals. However, the relationship between what services the hospital provides and what prices they report is not clear. We assessed reported prices in the Turquoise Health database and compared them at the hospital level with the CMS Provider of Services File to identify if a shoppable service was provided at a hospital. We found significant mismatch between the hospital prices being reported and the services being provided. For example, 56% of hospitals providing at least 1 shoppable service that requires public price reporting did not report any prices. Of hospitals reporting prices, most hospitals (66%) reported prices for only a portion of the services they provide. In addition, 12% of hospitals reported prices for services they do not provide. Only 6% of hospitals had complete concordance with price reporting and services they actually provide. Current compliance enforcement and penalties do not appear to be adequate to achieve the goals of the Hospital Price Transparency Rule.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363865/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perceptions of multi-cancer early detection tests among communities facing barriers to health care. 面临医疗保健障碍的社区对多种癌症早期检测试验的看法。
Pub Date : 2024-08-16 eCollection Date: 2024-09-01 DOI: 10.1093/haschl/qxae102
Kristi L Roybal, Robyn A Husa, Maria Connolly, Catherine Dinh, Kara M K Bensley, Staci J Wendt

Marginalized racial and ethnic groups and rural and lower income communities experience significant cancer inequities. Blood-based multi-cancer early detection tests (MCEDs) provide a simple and less invasive method to screen for multiple cancers at a single access point and may be an important strategy to reduce cancer inequities. In this qualitative study, we explored barriers and facilitators to MCED adoption among communities facing health care access barriers in Alaska, California, and Oregon. We used reflexive thematic analysis to analyze general barriers to cancer screening, MCED-specific barriers, facilitators of MCED adoption, and MCED communication strategies. We found barriers and facilitators to MCED adoption across 4 levels of the social-ecological model: (1) individual, (2) interpersonal, (3) health care system, and (4) societal. These included adverse psychological impacts, positive perceptions of MCEDs, information and knowledge about cancer screening, the quality of the patient-provider relationship, a lack of health care system trustworthiness, logistical accessibility, patient supports, and financial accessibility. Optimal MCED communication strategies included information spread through the medical environment and the community. These findings underscore the importance of understanding and addressing the multilevel factors that may influence MCED adoption among communities facing health care access barriers to advance health equity.

边缘化的种族和民族群体以及农村和低收入社区经历着严重的癌症不公平现象。基于血液的多种癌症早期检测试剂盒(MCED)提供了一种简单、侵入性较低的方法,可在单一就医点筛查多种癌症,可能是减少癌症不平等的重要策略。在这项定性研究中,我们探讨了阿拉斯加州、加利福尼亚州和俄勒冈州面临医疗服务获取障碍的社区采用 MCED 的障碍和促进因素。我们采用了反思性主题分析法来分析癌症筛查的一般障碍、MCED 的特定障碍、采用 MCED 的促进因素以及 MCED 的沟通策略。我们发现,采用 MCED 的障碍和促进因素横跨社会生态模型的 4 个层面:(1)个人;(2)人际;(3)医疗保健系统;(4)社会。这些障碍包括不良心理影响、对 MCED 的积极看法、有关癌症筛查的信息和知识、患者与医护人员关系的质量、医疗保健系统缺乏可信度、后勤便利性、患者支持以及经济便利性。最佳的 MCED 传播策略包括通过医疗环境和社区传播信息。这些发现强调了了解和解决可能影响社区采用 MCED 的多层次因素的重要性,这些因素可能会影响面临医疗服务获取障碍的社区采用 MCED,从而促进健康公平。
{"title":"Perceptions of multi-cancer early detection tests among communities facing barriers to health care.","authors":"Kristi L Roybal, Robyn A Husa, Maria Connolly, Catherine Dinh, Kara M K Bensley, Staci J Wendt","doi":"10.1093/haschl/qxae102","DOIUrl":"10.1093/haschl/qxae102","url":null,"abstract":"<p><p>Marginalized racial and ethnic groups and rural and lower income communities experience significant cancer inequities. Blood-based multi-cancer early detection tests (MCEDs) provide a simple and less invasive method to screen for multiple cancers at a single access point and may be an important strategy to reduce cancer inequities. In this qualitative study, we explored barriers and facilitators to MCED adoption among communities facing health care access barriers in Alaska, California, and Oregon. We used reflexive thematic analysis to analyze general barriers to cancer screening, MCED-specific barriers, facilitators of MCED adoption, and MCED communication strategies. We found barriers and facilitators to MCED adoption across 4 levels of the social-ecological model: (1) individual, (2) interpersonal, (3) health care system, and (4) societal. These included adverse psychological impacts, positive perceptions of MCEDs, information and knowledge about cancer screening, the quality of the patient-provider relationship, a lack of health care system trustworthiness, logistical accessibility, patient supports, and financial accessibility. Optimal MCED communication strategies included information spread through the medical environment and the community. These findings underscore the importance of understanding and addressing the multilevel factors that may influence MCED adoption among communities facing health care access barriers to advance health equity.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11363867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons for cannabinoid regulation from electronic nicotine delivery system product regulation. 电子尼古丁给药系统产品监管对大麻素监管的启示。
Pub Date : 2024-08-16 eCollection Date: 2024-08-01 DOI: 10.1093/haschl/qxae101
Brian Yagi, Stan Veuger, Brian J Miller, Paul Larkin

Cannabis legalization continues to spread, with 38 states permitting the use of medical marijuana, 22 states permitting recreational use, and growing political momentum for federal legalization. The last time the Food and Drug Administration (FDA) was tasked with regulating a new product occurred with 2009's Family Smoking Prevention and Tobacco Control Act, which created the Center for Tobacco Products (CTP). Thus, the time is ripe to review the history of CTP with particular attention to difficulties the nascent center faced in regulating novel products such as e-cigarettes or electronic nicotine delivery systems (ENDS). Specifically, FDA has struggled with defining its scope of authority, determining which review pathway(s) to utilize, and promulgating timely and transparent product standards for marketing authorization-all of which offer lessons for improving cannabis product oversight and enforcement.

大麻合法化在不断扩大,目前已有 38 个州允许使用医用大麻,22 个州允许使用娱乐性大麻,联邦大麻合法化的政治势头也在不断增强。食品药品管理局(FDA)上一次负责监管新产品是在 2009 年的《家庭吸烟预防和烟草控制法案》中,该法案设立了烟草产品中心(CTP)。因此,回顾烟草制品中心历史的时机已经成熟,尤其要关注新生的中心在监管电子烟或电子尼古丁输送系统(ENDS)等新产品时面临的困难。具体来说,食品和药物管理局在界定其权力范围、确定使用哪种审查途径以及及时颁布透明的产品标准以获得营销授权等方面都遇到了困难,所有这些都为改进大麻产品的监督和执法提供了借鉴。
{"title":"Lessons for cannabinoid regulation from electronic nicotine delivery system product regulation.","authors":"Brian Yagi, Stan Veuger, Brian J Miller, Paul Larkin","doi":"10.1093/haschl/qxae101","DOIUrl":"https://doi.org/10.1093/haschl/qxae101","url":null,"abstract":"<p><p>Cannabis legalization continues to spread, with 38 states permitting the use of medical marijuana, 22 states permitting recreational use, and growing political momentum for federal legalization. The last time the Food and Drug Administration (FDA) was tasked with regulating a new product occurred with 2009's Family Smoking Prevention and Tobacco Control Act, which created the Center for Tobacco Products (CTP). Thus, the time is ripe to review the history of CTP with particular attention to difficulties the nascent center faced in regulating novel products such as e-cigarettes or electronic nicotine delivery systems (ENDS). Specifically, FDA has struggled with defining its scope of authority, determining which review pathway(s) to utilize, and promulgating timely and transparent product standards for marketing authorization-all of which offer lessons for improving cannabis product oversight and enforcement.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350284/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictors of telehealth use after the Minnesota Telehealth Act: analysis using the Minnesota All Payer Claims Database. 明尼苏达州远程医疗法案》颁布后远程医疗使用的预测因素:使用明尼苏达州所有支付方索赔数据库进行分析。
Pub Date : 2024-08-16 eCollection Date: 2024-08-01 DOI: 10.1093/haschl/qxae100
Arkadipta Ghosh, Ethan Jacobs, Elizabeth Greener, Alyssa Evans, Mark Lee, Rui Wang, Pamela Mink, Michael Burian

During the COVID-19 pandemic, the federal government and many state governments instituted expanded coverage for telehealth (TH) services and since have maintained it. Using data from the Minnesota All Payer Claims Database and publicly available data sources, we examined TH use among commercially insured and Medicare Advantage (MA) patients in Minnesota. In 2022, 30.4% of commercially insured patients and 24.4% of MA patients used TH services. Living in a metropolitan area, an area with a high proportion of Black, Indigenous, and People of Color residents, having greater disease burden, and being younger were associated with a greater likelihood of using TH. Living in an area with limited broadband access reduced the likelihood of TH use. Two patient subgroups more likely to use TH-younger patients in metropolitan areas and high-risk patients with depression-received a similar proportion of ambulatory visits via TH.

在 COVID-19 大流行期间,联邦政府和许多州政府扩大了远程医疗(TH)服务的覆盖范围,并一直保持至今。利用明尼苏达州所有支付方索赔数据库和公开数据源中的数据,我们研究了明尼苏达州商业保险和医疗保险优势(MA)患者使用远程医疗服务的情况。2022 年,30.4% 的商业保险患者和 24.4% 的医疗保险患者使用了 TH 服务。居住在大都市地区、黑人、土著和有色人种居民比例较高的地区、疾病负担较重以及年龄较轻的人更有可能使用医疗服务。生活在宽带接入受限的地区会降低使用 TH 的可能性。两个更有可能使用门诊服务的患者亚群--大都市地区的年轻患者和抑郁症高危患者--通过门诊服务接受门诊就诊的比例相似。
{"title":"Predictors of telehealth use after the Minnesota Telehealth Act: analysis using the Minnesota All Payer Claims Database.","authors":"Arkadipta Ghosh, Ethan Jacobs, Elizabeth Greener, Alyssa Evans, Mark Lee, Rui Wang, Pamela Mink, Michael Burian","doi":"10.1093/haschl/qxae100","DOIUrl":"https://doi.org/10.1093/haschl/qxae100","url":null,"abstract":"<p><p>During the COVID-19 pandemic, the federal government and many state governments instituted expanded coverage for telehealth (TH) services and since have maintained it. Using data from the Minnesota All Payer Claims Database and publicly available data sources, we examined TH use among commercially insured and Medicare Advantage (MA) patients in Minnesota. In 2022, 30.4% of commercially insured patients and 24.4% of MA patients used TH services. Living in a metropolitan area, an area with a high proportion of Black, Indigenous, and People of Color residents, having greater disease burden, and being younger were associated with a greater likelihood of using TH. Living in an area with limited broadband access reduced the likelihood of TH use. Two patient subgroups more likely to use TH-younger patients in metropolitan areas and high-risk patients with depression-received a similar proportion of ambulatory visits via TH.</p>","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11350286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142116461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing the Future of Equitable Access to Health Care: Recommendations from International Health Care Leaders 推进公平获得医疗服务的未来:国际医疗保健领导人的建议
Pub Date : 2024-08-09 DOI: 10.1093/haschl/qxae094
Beth Boyer, Katie Huber, Eyal Zimlichman, Robert S Saunders, Mark McClellan, Charles N. Kahn, Ryan Noach, Claudia Salzberg
Disparities in access to health care are persistent and contribute to poor health outcomes for many populations around the world. Barriers to access are often similar across countries, despite differences in how health systems are structured. Health care leaders can work to address these barriers through bold, evidence-based actions. The Future of Health (FOH), an international community of senior health leaders, collaborated with the Duke-Margolis Institute for Health Policy to identify priority organizational and policy actions needed to improve equitable access to health care through a consensus-building exercise, a targeted literature review, and an expert discussion group. This paper describes four key action areas for health care leaders that FOH members identified as critical to enabling the future of equitable access to health care: ensuring prioritization of and accountability for equitable access to care; establishing comprehensive, organization-wide strategies to address barriers to access; clearly defining and incentivizing improvement on key measures related to reducing disparities in access; and establishing cross-sector partnerships to improve equitable access.
获得医疗服务方面的差距长期存在,导致世界各地许多人的健康状况不佳。尽管各国医疗系统的结构不同,但获得医疗服务的障碍往往相似。医疗保健领导者可以通过大胆的、以证据为基础的行动来消除这些障碍。健康的未来(FOH)是一个由资深卫生领袖组成的国际社区,它与杜克大学马戈利斯卫生政策研究所合作,通过建立共识、有针对性的文献回顾和专家讨论小组,确定了改善公平获得医疗服务所需的优先组织和政策行动。本文介绍了 FOH 成员为医疗保健领导者确定的四个关键行动领域,这四个领域对于实现未来公平获得医疗保健服务至关重要:确保优先考虑公平获得医疗保健服务并对其负责;建立全面的、全组织范围的战略,以解决获得医疗保健服务的障碍;明确界定并激励改善与减少获得医疗保健服务差距相关的关键措施;以及建立跨部门合作伙伴关系,以改善公平获得医疗保健服务。
{"title":"Advancing the Future of Equitable Access to Health Care: Recommendations from International Health Care Leaders","authors":"Beth Boyer, Katie Huber, Eyal Zimlichman, Robert S Saunders, Mark McClellan, Charles N. Kahn, Ryan Noach, Claudia Salzberg","doi":"10.1093/haschl/qxae094","DOIUrl":"https://doi.org/10.1093/haschl/qxae094","url":null,"abstract":"\u0000 Disparities in access to health care are persistent and contribute to poor health outcomes for many populations around the world. Barriers to access are often similar across countries, despite differences in how health systems are structured. Health care leaders can work to address these barriers through bold, evidence-based actions. The Future of Health (FOH), an international community of senior health leaders, collaborated with the Duke-Margolis Institute for Health Policy to identify priority organizational and policy actions needed to improve equitable access to health care through a consensus-building exercise, a targeted literature review, and an expert discussion group. This paper describes four key action areas for health care leaders that FOH members identified as critical to enabling the future of equitable access to health care: ensuring prioritization of and accountability for equitable access to care; establishing comprehensive, organization-wide strategies to address barriers to access; clearly defining and incentivizing improvement on key measures related to reducing disparities in access; and establishing cross-sector partnerships to improve equitable access.","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141925326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Putting Meat on the Bone: How to Fast-Track Innovative Medicines to Those Who Need Them and Generate Data to Justify Continued Use 有的放矢:如何将创新药物快速提供给需要者,并生成数据证明继续使用的合理性
Pub Date : 2024-08-09 DOI: 10.1093/haschl/qxae095
Daniel Ollendorf, Chris Henshall, Marie Phillips, Patricia Synnott, Lloyd Sansom, Sean Tunis
Regulatory agencies worldwide have taken significant steps to expedite approval and market authorization of medicines based on their potential to address areas of significant unmet medical need and severe disease burden. But initial approval of such medicines is often accompanied by limited evidence of benefit, posing a conundrum for payers and health systems who may desire greater certainty of their value. This paper describes a system of “accelerated access” to manage these tensions and coordinate activities across stakeholders, based on discussions held at a multi-stakeholder convening in June 2023. We focus on 6 core, near-term actions that can be taken to improve the current system: clarifying criteria for expedited regulatory approval; enhancing stakeholder coordination; creating expedited pathways in payer and health technology assessment settings; developing joint regulatory/payer/HTA guidance on study design and data needs; linking pricing policy to data uncertainty; and improving patient and public understanding of the processes involved as well as the risks and benefits of the relevant medicines. Many of these actions will require additional resources and personnel, and some will necessitate unprecedented levels of coordination. Nevertheless, each action is designed to work with minimal adjustments to the current system rather than demanding an entirely new approach.
世界各地的监管机构已采取重大措施,根据药品在满足重大未满足医疗需求和减轻严重疾病负担方面的潜力,加快药品的审批和上市。但是,此类药物在获得初步批准时,往往只有有限的获益证据,这给支付方和医疗系统带来了难题,因为他们可能希望这些药物的价值能够更加确定。本文根据 2023 年 6 月召开的多方利益相关者会议的讨论情况,介绍了一种 "加速获取 "系统,以管理这些矛盾并协调各利益相关者的活动。我们重点讨论了可用于改善当前系统的 6 项核心近期行动:明确加快监管审批的标准;加强利益相关者之间的协调;在支付方和卫生技术评估环境中创建加速路径;就研究设计和数据需求制定监管/支付方/卫生技术评估联合指南;将定价政策与数据不确定性联系起来;以及提高患者和公众对相关流程以及相关药物的风险和益处的理解。其中许多行动需要额外的资源和人员,有些行动需要前所未有的协调。尽管如此,每项行动都旨在对现行制度进行最小程度的调整,而不是要求采用全新的方法。
{"title":"Putting Meat on the Bone: How to Fast-Track Innovative Medicines to Those Who Need Them and Generate Data to Justify Continued Use","authors":"Daniel Ollendorf, Chris Henshall, Marie Phillips, Patricia Synnott, Lloyd Sansom, Sean Tunis","doi":"10.1093/haschl/qxae095","DOIUrl":"https://doi.org/10.1093/haschl/qxae095","url":null,"abstract":"\u0000 Regulatory agencies worldwide have taken significant steps to expedite approval and market authorization of medicines based on their potential to address areas of significant unmet medical need and severe disease burden. But initial approval of such medicines is often accompanied by limited evidence of benefit, posing a conundrum for payers and health systems who may desire greater certainty of their value. This paper describes a system of “accelerated access” to manage these tensions and coordinate activities across stakeholders, based on discussions held at a multi-stakeholder convening in June 2023. We focus on 6 core, near-term actions that can be taken to improve the current system: clarifying criteria for expedited regulatory approval; enhancing stakeholder coordination; creating expedited pathways in payer and health technology assessment settings; developing joint regulatory/payer/HTA guidance on study design and data needs; linking pricing policy to data uncertainty; and improving patient and public understanding of the processes involved as well as the risks and benefits of the relevant medicines. Many of these actions will require additional resources and personnel, and some will necessitate unprecedented levels of coordination. Nevertheless, each action is designed to work with minimal adjustments to the current system rather than demanding an entirely new approach.","PeriodicalId":94025,"journal":{"name":"Health affairs scholar","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141924197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health affairs scholar
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1